Is Science the true starting point for innovation? Discover why the linear model is failing and how the dynamic cycle of Manufacturing, Science, and Technology Transfer is the real engine of progress.
Blog
Building Once, Validating Forever: Why Scalable CQV Is the Future-Proof Strategy Life Sciences Manufacturers Can’t Ignore – Scalability is the difference between a validation program that becomes a growing liability and one that becomes a strategic asset as your operation expands.
The Future of the Modern Laboratory Is Here: Introducing Mivado GlobalPerformance’s AI-Driven LIMS – In today’s fast-paced scientific and industrial landscape, laboratories are under more pressure than ever to deliver faster results and maintain airtight compliance.
Tagged : AI, AI-LIMS, APQR, Biopharma, Biopharmaceutical, Compliance, Digital Transformation, Digitalization, GxP, Health Canada, LIMS, Quality 4.0
Risk Evaluation in Biopharmaceutical Technology Transfer: Why a Risk-Based Approach Is Essential for GMP Success. Successful biopharmaceutical technology transfer depends on more than process knowledge.
Tagged : Biopharmaceutical, Compliance, GxP, MSAT, QRM, Quality 4.0, Risk Management, Technology Transfer
Drafting Perfect 483 Responses: The New FDA Guidelines Explained. FDA Form 483 observations are issued when investigators identify conditions that may violate cGMP requirements.